Burden of Alzheimer Disease Rose Worldwide From 1990 to 2021
By Lori Solomon HealthDay Reporter
THURSDAY, March 20, 2025 -- The burden of Alzheimer disease and other dementias (ADODs) rose globally from 1990 to 2021, according to a study published online in the April issue of the American Journal of Preventive Medicine.
Manqiong Yuan, from Xiamen University in China, and colleagues described the global burden and temporal trends of ADODs from 1990 to 2021 using data from the Global Burden of Disease 2021 study.
The researchers found significant disparities in the numbers, rates, and age-standardized rates of disability-adjusted life years across 204 countries/territories. For all age groups, women demonstrated higher disability-adjusted life-year numbers (rates). Worldwide, there was an increase in the age-standardized disability-adjusted life-year rate, which was high in high-middle and middle sociodemographic index regions but increased faster in low (average annual percentage change [AAPC], 0.227 percent) and low-middle (AAPC, 0.244 percent) sociodemographic index regions. Disability-adjusted life years of ADODs were skewed and higher in countries with higher sociodemographic development, with the inequality increasing over time except for education expenditure-related inequality.
“Based on the results, it is necessary to further control risk factors of ADODs by promoting a healthy diet and regular exercise for preventing the development of ADODs in developed countries," lead author Ya Fang, M.D., Ph.D., also from Xiamen University, said in a statement. "However, enhancing basic healthcare, improving medical resource access and affordability, and raising ADOD awareness among the public in developing countries are also vital."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Sense of Life Purpose Lowers Risk for Cognitive Impairment
THURSDAY, Sept. 4, 2025 -- A sense of purpose in life (PiL) is associated with a lower risk for and later onset of cognitive impairment, according to a study published online in...
Intake of Low-, No-Calorie Sweeteners Tied to Faster Cognitive Decline
WEDNESDAY, Sept. 3, 2025 -- Consumption of low- and no-calorie sweeteners (LNCSs) is associated with faster cognitive decline, according to a study published online Sept. 3 in...
Type of Hormone Therapy Used After Menopause Affects Memory Performance
FRIDAY, Aug. 29, 2025 -- Earlier age at menopause is associated with lower scores on all cognitive domains, and menopausal hormone therapy (MHT) differentially affects cognition...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.